Guidance for professionals
The filter and search function on this page allows you to refine down the full list of guidance that we provide for professionals to find specific items. Common searches for the HTA codes of practice and standards, licensing, fees and inspection information or for specific information for each of our regulated sectors can be found using the menu items above.
Notice for Designated Individuals in the Human Application sector regarding Viaspan solution, which is distributed by Bristol Myers-Squibb.
This policy outlines the approach the Human Tissue Authority (HTA) takes when dealing with allegations about individuals or establishments (licensed or unlicensed) that fall into the HTA’s regulatory remit.
Information for regional resilience teams on licensing of emergency mortuaries.
Notice for Designated Individuals in the Human application sector regarding the Hepatitis C virus total antibody kit manufactured by Abbott GmbH & Co. KG and distributed in the UK by Abbott Diagnostics_x000D_
_x000D_
Resolving complaints can improve the Human Tissue Authority’s (HTA’s) services and support the HTA’s reputation.
This page contains all the information hospitals and trusts need when considering adopting the Sands post mortem consent form. This form was developed in conjunction with the HTA, by the Stillbirth and Neonatal Death charity (Sands).
Medfor Femoral Head Storage Pots (S400).
HTA policy on human tissue xenografts as relevant material, the consent implications and the licensing requirements under the HT Act 2004.
This page covers the skills and knowledge which Sands' believes is necessary for those seeking consent/authorisation for a hospital post mortem examination of a baby. Sands is the stillbirth and neonatal death charity.
Traceability of stem cells distributed by Advanced Cell Therapeutics / Biomark / CellTech / BioCells